Skip to Content

What is the cost of Kymriah?

Answers (1)

Official Answer by Drugs.com 10 Oct 2017
According to Novartis, the manufacturer of Kymriah (tisagenlecleucel), the cancer therapy will cost $475,000 for one treatment course. Kymriah is a chimeric antigen receptor T cell (CAR-T) therapy for use in pediatric and young adult patients (up to age 25) with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL).
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 13 days ago 1 answerFAQ by Drugs.com

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 11 days ago 1 answerFAQ by Drugs.com

How do you use the ProAir Digihaler?

Updated 11 days ago 1 answerFAQ by Drugs.com

How many biosimilars have been approved in the United States?

Updated 10 days ago 1 answerFAQ by Drugs.com